4-Deschloro-4-bromo Dapagliflozin

• CAT Number: R031851
• CAS Number: 1807632-95-6
• Molecular Formula: C21H25BrO6
• Molecular Weight: 453.329
• Purity: ≥95%
• Synonyms: (1S)-1,5-Anhydro-1-C-[4-bromo-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol; Dapagliflozin Impurity 3
• Storage: Store at -20℃
• IUPAC Name: (2S,3R,4R,5S,6R)-2-[4-bromo-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
• InChI: InChI=1S/C21H25BrO6/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21/h3-8,10,17-21,23-26H,2,9,11H2,1H3/t17-,18-,19+,20-,21+/m1/s1
• InChIKey: UABOQFANGSVXKK-ADAARDCZSA-N
• SMILES: CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Br

4-Deschloro-4-bromo dapagliflozin is a synthetic derivative of dapagliflozin, a medication used to treat type 2 diabetes. This compound involves the replacement of a chlorine atom with a bromine atom in the dapagliflozin molecule. As an SGLT2 inhibitor, it helps lower blood glucose levels by preventing glucose reabsorption in the kidneys, offering potential therapeutic benefits in managing diabetes.